Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N M Agrawal

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
The American Journal of Gastroenterology|August 5, 2000
Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitorJ L Goldstein, F E Silverstein, N M Agrawal, et al.
The Journal of Rheumatology|August 24, 2000
Upper gastrointestinal tolerability of celecoxib, a COX-2 specific inhibitor, compared to naproxen and placeboW G Bensen, S Z Zhao, T A Burke, et al.
JAMA|September 9, 2000
Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety StudyF E Silverstein, G Faich, J L Goldstein, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
The American Journal of Gastroenterology|August 5, 2000
Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitorJ L Goldstein, F E Silverstein, N M Agrawal, et al.
The Journal of Rheumatology|August 24, 2000
Upper gastrointestinal tolerability of celecoxib, a COX-2 specific inhibitor, compared to naproxen and placeboW G Bensen, S Z Zhao, T A Burke, et al.
JAMA|September 9, 2000
Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety StudyF E Silverstein, G Faich, J L Goldstein, et al.
Pageof 4